The overall death rate from high blood pressure in the United States has increased 23% since 2000, even as the death rate from all other causes has dropped 21%, health officials reported.
The overall death rate from high blood pressure in the United States has increased 23% since 2000, even as the death rate from all other causes has dropped 21%, health officials reported Thursday.
That spike was seen in both genders and was most marked among those aged 45 to 64 and those over 85, according to a new report from the CDC.
"The age-adjusted deaths from high blood pressure went up, while the other causes of death went down," said report author Hsiang-Ching Kung, a statistician with CDC's National Center for Health Statistics.
Read more at Medical Xpress: http://bit.ly/1BQc6uJ
Survival Rates in CLL: Targeted Agents vs Fludarabine Combo Therapy Study
April 17th 2024Researchers conducted an analysis of 4 phase 3 trials, covering 2751 patients, to address the potential for targeted agents in younger and physically fit patients who have chronic lymphocytic leukemia (CLL).
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More